Congo vs Lao People's Democratic Republic: Average cost of multi drug-resistant tuberculosis treatment
Congo
726 constant 2022 US$
in 2024
Lao People's Democratic Republic
756 constant 2022 US$
in 2024
Congo rank
66th
Lao People's Democratic Republic rank
64th
Average cost of multi drug-resistant tuberculosis treatment over time
- Congo
- Lao People's Democratic Republic
How they compare
Lao People's Democratic Republic currently reports 756 constant 2022 US$ against 726 constant 2022 US$ in Congo, a difference of 30 constant 2022 US$.
The two have swapped places 1 time across 8 shared years of data; in 2017 it was Congo ahead.
Congo ranks 66th and Lao People's Democratic Republic ranks 64th of 92 countries.
Across the 2 decades both report, Congo averaged higher in 1 and Lao People's Democratic Republic in 1.
Head to head by decade
| Decade | Congo | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1,793 constant 2022 US$ | 1,322 constant 2022 US$ | 471 constant 2022 US$ | Congo |
| 2020s | 671.8 constant 2022 US$ | 951.2 constant 2022 US$ | 279.4 constant 2022 US$ | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average cost of multi drug-resistant tuberculosis treatment, Congo or Lao People's Democratic Republic?
- Lao People's Democratic Republic, at 756 constant 2022 US$ against 726 constant 2022 US$ in Congo as of 2024.
- What is the difference in average cost of multi drug-resistant tuberculosis treatment between Congo and Lao People's Democratic Republic?
- 30 constant 2022 US$, with Lao People's Democratic Republic ahead.
- How many years of comparable data are there for Congo and Lao People's Democratic Republic?
- 8 years are reported by both, from 2017 to 2024.
- How do Congo and Lao People's Democratic Republic rank globally for average cost of multi drug-resistant tuberculosis treatment?
- Congo ranks 66th and Lao People's Democratic Republic ranks 64th of 92 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Average cost of multi drug-resistant tuberculosis treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Average cost of drugs spent per patient starting multidrug-resistant tuberculosis treatment, excluding buffer stock.